NEUROPILIN-2: NOVEL BIOMARKER AND THERAPEUTIC TARGET FOR AGGRESSIVE PROSTATE CANCER

$1,233,750FY2012Department of DefenseDOD

University Of Massachusetts Medical School, Worcester MA

Investigators